MED-LIFE DISCOVERIES | the science of prevention

NEWS
February 16, 2017. Shawn and Tara will be attending the World Orphan Disease Drug Conference in Washington DC, April 19 to 21.
January 24, 2017. Gavin Preston appointed Managing Director of Med-Life Discoveries.
January 13, 2017. We welcome back Dr. Tara Smith as Senior Scientist and Team Leader of our Therapeutics Division.
ONCOLOGY
Stacks Image 123
Learn about our blood tests that detect risk of colorectal cancer and pancreatic cancer among the general population.
ALZHEIMER'S DISEASE
Stacks Image 48
RCDP
Stacks Image 52
RCDP is a rare pediatric genetic disorder that affects peroxisome function. Our plasmalogen replacement might be the key. Learn more.
MULTIPLE SCLEROSIS
Stacks Image 77
Our plasmalogen therapy might restore the lipid component of myelin lost during the progression of Multiple Sclerosis. Learn more.



PARKINSON'S DISEASE
Stacks Image 84
The treatment of Parkinson's disease with L-DOPA eventually leads to dyskinesias. Our data shows that plasmalogen replacement might help.

LABORATORY SERVICES
Stacks Image 91
Our mass spectrometry lab is CLIA certified and licensed by CPSS. Learn more.


At MED-LIFE DISCOVERIES, we believe in a future where disease is not just treated, but prevented. Unlike conventional screening tests that detect symptoms of a disease, our research and development focuses on what goes wrong in the body - before a disease develops.

Biochemical changes within the body occur long before the symptoms of diseases such as cancer and Alzheimer's appear. This pre-symptomatic phase represents the perfect window to identify those with increased risk, and to therapeutically correct the biochemical imbalance.